Assyro AI

FDA Orange Book · active-ingredient family

Magnesium sulfate; potassium chloride; sodium sulfate

Magnesium sulfate; potassium chloride; sodium sulfate is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SUTAB · NDA 213135

1

Brand (NDA)

1

Generics (ANDA)

4

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
SUTABRLDAZURITYNDA 213135ABNov 10, 2020

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDELUPINANDA 216095ABMay 28, 2026

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11382864Aug 04, 2037in 11 yr 3 mo
U-3164
11033498Aug 04, 2037in 11 yr 3 mo
U-3164
11638697Aug 04, 2037in 11 yr 3 mo
Product
10143656Aug 04, 2037in 11 yr 3 mo
Product

Magnesium sulfate; potassium chloride; sodium sulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.